Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study

• Published in: Arthritis research & therapy Vol. 12; no. 6; p. R213
• Main Authors: Mikuls, Ted R, Gould, Karen A, Bynoté, Kimberly K, Yu, Fang, Levan, Tricia D, Thiele, Geoffrey M, Michaud, Kaleb D, O'Dell, James R, Reimold, Andreas M, Hooker, Roderick, Caplan, Liron, Johnson, Dannette S, Kerr, Gail, Richards, J Steuart, Cannon, Grant W, Criswell, Lindsey A, Noble, Janelle A, Bridges, Jr, S Louis, Hughes, Laura, Gregersen, Peter K
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.01.2010; BioMed Central
• Subjects: Antibodies; Arthritis, Rheumatoid - blood; Arthritis, Rheumatoid - genetics; Arthritis, Rheumatoid - immunology; Autoantibodies - blood; Autoantibodies - genetics; Autoantibodies - immunology; Autoantigens - immunology; Cross-Sectional Studies; Development and progression; Enzyme-Linked Immunosorbent Assay; Enzymes; Epitopes - genetics; Epitopes - immunology; Female; Gene expression; Genetic aspects; Genetic Predisposition to Disease; Genotype; Glutathione Transferase - genetics; Health aspects; HLA-DR Antigens - genetics; HLA-DRB1 Chains; Humans; Male; Middle Aged; Physiological aspects; Polymerase Chain Reaction; Polymorphism, Genetic; Rheumatoid arthritis; Viral antibodies
• ISSN: 1478-6354; 1478-6362
• DOI: 10.1186/ar3190

A deletion polymorphism in glutathione S-transferase Mu-1 (GSTM1-null) has previously been implicated to play a role in rheumatoid arthritis (RA) risk and progression, although no prior investigations have examined its associations with anticitrullinated protein antibody (ACPA) positivity. The purpose of this study was to examine the associations of GSTM1-null with ACPA positivity in RA and to assess for evidence of interaction between GSTM1 and HLA-DRB1 shared epitope (SE). Associations of GSTM1-null with ACPA positivity were examined separately in two RA cohorts, the Veterans Affairs Rheumatoid Arthritis (VARA) registry (n = 703) and the Study of New-Onset RA (SONORA; n = 610). Interactions were examined by calculating an attributable proportion (AP) due to interaction. A majority of patients in the VARA registry (76%) and SONORA (69%) were positive for ACPA with a similar frequency of GSTM1-null (53% and 52%, respectively) and HLA-DRB1 SE positivity (76% and 71%, respectively). The parameter of patients who had ever smoked was more common in the VARA registry (80%) than in SONORA (65%). GSTM1-null was significantly associated with ACPA positivity in the VARA registry (odds ratio (OR), 1.45; 95% confidence interval (CI), 1.02 to 2.05), but not in SONORA (OR, 1.00; 95% CI, 0.71 to 1.42). There were significant additive interactions between GSTM1 and HLA-DRB1 SE in the VARA registry (AP, 0.49; 95% CI, 0.21 to 0.77; P < 0.001) in ACPA positivity, an interaction replicated in SONORA (AP, 0.38; 95% CI, 0.00 to 0.76; P = 0.050). This study is the first to show that the GSTM1-null genotype, a common genetic variant, exerts significant additive interaction with HLA-DRB1 SE on the risk of ACPA positivity in RA. Since GSTM1 has known antioxidant functions, these data suggest that oxidative stress may be important in the development of RA-specific autoimmunity in genetically susceptible individuals.